(Q39655875)

13 September 2017

title

Mature B cells are critical to T-cell-mediated tumor immunity induced by an agonist anti-GITR monoclonal antibody (English)

1 reference

13 September 2017

Mature B Cells Are Critical to T-cell-mediated Tumor Immunity Induced by an Agonist Anti-GITR Monoclonal Antibody (English)

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

13 July 2024

1 reference

1 reference

Pengfei Zhou

1

1 reference

13 September 2017

Junzhuan Qiu

2

1 reference

13 September 2017

Lawrence L'Italien

3

1 reference

13 September 2017

Danling Gu

4

1 reference

13 September 2017

Douglas Hodges

5

1 reference

13 September 2017

Cheng-Chi Chao

6

1 reference

13 September 2017

Xiao Min Schebye

7

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20842058

13 July 2024

publication date

1 October 2010

1 reference

full work available at URL

13 September 2017

https://journals.lww.com/10.1097/CJI.0b013e3181ee6ba9

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

13 July 2024

published in

Journal of Immunotherapy

1 reference

13 September 2017

volume

33

1 reference

13 September 2017

issue

8

1 reference

13 September 2017

page(s)

789-797

1 reference

Effective cancer therapy through immunomodulation

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Cytokine control of memory T-cell development and survival

13 July 2024

2

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Soluble PD-1 facilitates 4-1BBL-triggered antitumor immunity against murine H22 hepatocarcinoma in vivo

13 July 2024

3

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

13 July 2024

5

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

13 July 2024

6

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Adoptive immunotherapy for cancer: building on success

13 July 2024

8

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Cancer regression in patients after transfer of genetically engineered lymphocytes

13 July 2024

9

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

13 July 2024

10

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

13 July 2024

11

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Antigen-specific interaction between T and B cells

13 July 2024

12

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

T cell-dependent B cell activation

13 July 2024

13

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells.

13 July 2024

14

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

A critical role for B cells in the development of memory CD4 cells.

13 July 2024

15

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Transcriptional targeting of B cells for induction of peripheral CD8 T cell tolerance.

13 July 2024

16

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

B-cells promote intra-islet CD8+ cytotoxic T-cell survival to enhance type 1 diabetes.

13 July 2024

17

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Reciprocal regulation of polarized cytokine production by effector B and T cells

13 July 2024

18

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Distinct profiles of human B cell effector cytokines: a role in immune regulation?

13 July 2024

19

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Autoantibodies to tumor-associated antigens: reporters from the immune system

13 July 2024

20

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Autoantibody signatures in prostate cancer

13 July 2024

21

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

p53 Antibodies in the sera of patients with various types of cancer: a review

13 July 2024

22

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells.

13 July 2024

23

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

B cells inhibit induction of T cell-dependent tumor immunity.

13 July 2024

24

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent

13 July 2024

25

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma.

13 July 2024

26

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

B-Lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cells.

13 July 2024

27

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

13 July 2024

28

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent

13 July 2024

29

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Prognostic significance of autoimmunity during treatment of melanoma with interferon.

13 July 2024

30

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade

13 July 2024

31

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Role of the progesterone receptor for paclitaxel resistance in primary breast cancer.

13 July 2024

32

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity.

13 July 2024

33

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Pivotal roles of CD4+ effector T cells in mediating agonistic anti-GITR mAb-induced-immune activation and tumor immunity in CT26 tumors

13 July 2024

34

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

13 July 2024

35

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus

13 July 2024

36

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation

13 July 2024

37

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy

13 July 2024

38

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+ CD4 T cells

13 July 2024

39

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets

13 July 2024

40

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

A case for regulatory B cells

13 July 2024

41

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

In the absence of a CD40 signal, B cells are tolerogenic.

13 July 2024

42

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants

13 July 2024

43

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Inhibitory effects of B cells on antitumor immunity.

13 July 2024

44

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

TNF/TNFR family members in costimulation of T cell responses

13 July 2024

45

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity

13 July 2024

46

1 reference

https://api.crossref.org/works/10.1097/CJI.0B013E3181EE6BA9

13 July 2024

Identifiers

1 reference

13 September 2017

1 reference